Categories
Genel

BioNTech/Pfizer to request approval for new Covid-19 shot that lasts up to 6 months at fridge temperatures — RT World News From “RT World News”



The CEO of BioNTech has said the company and its US partner Pfizer will seek approval for a new version of their Covid-19 vaccine that can be stored at normal refrigerator temperatures for up to six months.

At a webcast event organized by the Financial Times on Tuesday, BioNTech’s CEO and co-founder Ugur Sahin said the new version of their much sought-after Covid-19 vaccine could be stored in temperature between two and eight degrees Celsius for a period of up to six months. “Our first formulation had to be stored and shipped at -80 degrees. We now have a formulation, which is not yet approved … that can be stored at two to eight degrees,” Sahin told those watching. 

Also on rt.com
Pfizer and BioNTech up Covid vaccine production capacity to 3 billion doses in 2021

“We will most likely reach six months’ stability at two to eight degrees,” he stated, adding that data packages were being readied to be sent out to regulators.While the current BioNTech/Pfizer jab has been widely used and is in high demand, the requirement to store the shot at super-cold temperatures means it has little utility in countries or regions without a network of such storage capabilities.At the same video conference, Sahin said BioNTech and Pfizer have been able to further increase production capacity of their Covid-19 vaccine, upping supply to around three billion doses in 2021.If you like this story, share it with a friend!







Read All

Categories
Genel

Confident BioNTech-Pfizer Vaccine Works Against Indian Variant: Founder From “NDTV News – World-news”



The vaccine is cleverly built, said BioNTech co-founder Ugur Sahin (File)Berlin: BioNTech co-founder Ugur Sahin on Wednesday voiced confidence that the vaccine that his company jointly developed with Pfizer works against the Indian variant of the coronavirus.”We are still testing the Indian variant, but the Indian variant has mutations that we have already tested for and which our vaccine works against, so I am confident,” said Mr Sahin.”The vaccine is cleverly built and I’m convinced the bulwark will hold. And if we have to strengthen the bulwark again, then we will do it, that I’m not worried about,” he added.The country is facing surging new cases and deaths in the pandemic, and fears are rising that the variant could be contributing to the unfolding catastrophe.The World Health Organization has said the B.1.617 variant of Covid-19 first found in the country had as of Tuesday been detected in “at least 17 countries”.The health agency recently listed B.1.617 — which counts several sub-lineages with slightly different mutations and characteristics — as a “variant of interest”.But so far it has stopped short of declaring it a “variant of concern”, which would have indicated that it is more dangerous than the original version of the virus by, for instance, being more transmissible, deadly or able to dodge vaccine protections.The BioNTech-Pfizer vaccine was the first to win authorisation in the West, and has since been deployed in dozens of countries worldwide.Giving an update of the authorisation process in China, Mr Sahin said approval was “very possible in July”.”We are almost through with all questions,” he said.







Read All